John A. Ballantyne Revocable Living Trust dated 08/01/2017 bought GCTK
March 12, 2025 · Form 4 insider transaction
John A. Ballantyne Revocable Living Trust dated 08/01/2017 bought 2,560,553 shares of GlucoTrack, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as exercise of in-the-money option and disclosed on an SEC Form 4, filed 19 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,560,553
Price
$0.00
Total value
N/A
Role—
CompanyGlucoTrack, Inc. (GCTK)
SecurityCommon Stock, par value $0.001 per share
Transaction codeX: Exercise of in-the-money option
Transaction dateMarch 12, 2025
Filing dateMarch 31, 2025
Shares owned after2,743,591
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On March 12, 2025, the Ballantyne Trust effected an Alternative Cashless Exercise of the Series B Common Warrants and exercised the warrants on a cashless basis via warrant exchange for 2,560,553 shares of Common Stock.